$1.00
-0.10-9.09%
At close: -
$1.00
0.000.00%
After Hours: Apr 4, 6:15 PM EDT
Comments
Loading...
Marker Therapeutics Analyst Ratings and Price Targets | NASDAQ:MRKR | Benzinga
Marker Therapeutics Inc has a consensus price target of $13.17 based on the ratings of 3 analysts. The high is $19 issued by Ladenburg Thalmann on October 21, 2024. The low is $8 issued by Canaccord Genuity on March 5, 2025. The 3 most-recent analyst ratings were released by WBB Securities, Canaccord Genuity, and Ladenburg Thalmann on April 1, 2025, March 5, 2025, and October 21, 2024, respectively. With an average price target of $13.17 between WBB Securities, Canaccord Genuity, and Ladenburg Thalmann, there's an implied 1216.67% upside for Marker Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
WBB Securities
Canaccord Genuity
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Marker Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/01/2025 | Buy Now | 1150% | WBB Securities | Steve Brozak21% | $12.5 → $12.5 | Reiterates | Strong Buy → Strong Buy | Get Alert |
| 03/05/2025 | Buy Now | 700% | Canaccord Genuity | John Newman43% | → $8 | Initiates | → Buy | Get Alert |
| 10/21/2024 | Buy Now | 1800% | Ladenburg Thalmann | Aydin Huseynov35% | $11 → $19 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 1000% | Ladenburg Thalmann | Aydin Huseynov35% | → $11 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Marker Therapeutics (MRKR) stock?
The latest price target for Marker Therapeutics (NASDAQ:MRKR) was reported by WBB Securities on April 1, 2025. The analyst firm set a price target for $12.50 expecting MRKR to rise to within 12 months (a possible 1150.00% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Marker Therapeutics (MRKR)?
The latest analyst rating for Marker Therapeutics (NASDAQ:MRKR) was provided by WBB Securities, and Marker Therapeutics reiterated their strong buy rating.
When was the last upgrade for Marker Therapeutics (MRKR)?
There is no last upgrade for Marker Therapeutics
When was the last downgrade for Marker Therapeutics (MRKR)?
There is no last downgrade for Marker Therapeutics.
When is the next analyst rating going to be posted or updated for Marker Therapeutics (MRKR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marker Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marker Therapeutics was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.
Is the Analyst Rating Marker Therapeutics (MRKR) correct?
While ratings are subjective and will change, the latest Marker Therapeutics (MRKR) rating was a reiterated with a price target of $12.50 to $12.50. The current price Marker Therapeutics (MRKR) is trading at is $1.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.